Found 21 articles for: "Hidradenitis"
The Efficacy of Intense Pulsed Light and Laser Hair Removal in Hidradenitis Suppurativa Treatment
November 2024 | Volume 23 | Issue 11 | Original Article | 926 | Copyright © November 2024
Background: Hidradenitis suppurativa (HS) is a multifactorial disease that presents with chronic cycles of inflammation, healing, and scarring and that elicits a profoundly negat...
Read MoreError: 429: HTTP/2 429Hidradenitis Suppurativa Found Associated With Cytokine Storm
May 2024 | Volume 23 | Issue 5 | | e134 | Copyright © May 2024
Background: Hidradenitis suppurativa (HS) is a chronic inflammatory disease that generates multiple cytokines. Here, we present an example of the cytokines forming a cytokine sto...
Read MoreError: 429: HTTP/2 429Complementary and Alternative Medicine for Hidradenitis Suppurativa Discussed on TikTok: A Cross-Sectional Analysis
March 2024 | Volume 23 | Issue 3 | | e93 | Copyright © March 2024
Background: Hidradenitis suppurativa (HS) is a painful, chronic inflammatory skin disease that negatively affects patient quality of life, and conventional treatments are variabl...
Read MoreError: 429: HTTP/2 429A New Tool to Improve Communication Between Hidradenitis Suppurativa Patients and Health Care Providers
February 2024 | Volume 23 | Issue 2 | | 105 | Copyright © February 2024
Background: Hidradenitis suppurativa (HS) patients tend to experience diagnosis delay, misdiagnosis, and embarrassment due to their condition. To address these issues, the Intern...
Read MoreError: 429: HTTP/2 429Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series
November 2023 | Volume 22 | Issue 11 | | e12 | Copyright © November 2023
Background: Management of hidradenitis suppurativa (HS) is challenging since no single treatment provides consistently effective results, leaving patients with frequent relapses....
Read MoreError: 429: HTTP/2 429A Review of the Current Landscape of Hidradenitis Suppurativa Treatment Development
October 2023 | Volume 22 | Issue 10 | | 1021 | Copyright © October 2023
Background: Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition characterized by recurrent nodules and abscesses leading to subsequent scarring and tunnel form...
Read MoreError: 429: HTTP/2 429Hormonal Treatments in Hidradenitis Suppurativa: A Systematic Review
August 2023 | Volume 22 | Issue 8 | | 785 | Copyright © August 2023
Background: Hidradenitis suppurativa (HS) is an inflammatory skin condition characterized by recurrent abscesses, nodules, and sinus tracts. Hormones are thought to play an impor...
Read MoreError: 429: HTTP/2 429Racial Disparities in the Treatment of Hidradenitis Suppurativa: An Analysis of Data from the National Ambulatory Medical Care Survey
July 2023 | Volume 22 | Issue 7 | | 692 | Copyright © July 2023
Hidradenitis suppurativa (HS) is a painful, disfiguring, chronic inflammatory disease affecting the axillary, inframammary, and groin regions. Black Americans are disproportionately affected by H...
Read MoreError: 429: HTTP/2 429Barriers to Dermatologic Care and Use of Internet Sources in Hidradenitis Suppurativa
July 2023 | Volume 22 | Issue 7 | | 710 | Copyright © July 2023
Poondru S, Scott K, Riley JM. Barriers to dermatologic care and use of internet sources in hidradenitis suppurativa. J Drugs Dermatol. 2023;22(7):710-711. doi:10.36849/JDD.7355....
Read MoreWomen of Childbearing Age With Hidradenitis Suppurativa Frequently Prescribed Medications With Pregnancy Risk
July 2023 | Volume 22 | Issue 7 | | 706 | Copyright © July 2023
Copy: Hidradenitis suppurativa (HS) disproportionately affects women of childbearing age. As almost half of pregnancies in the United States are unplanned, dermatologists must gi...
Read MoreError: 429: HTTP/2 429Increased Doses of Adalimumab are Associated With Clinical Improvement of Hidradenitis Suppurativa
June 2023 | Volume 22 | Issue 6 | | 615 | Copyright © June 2023
Background: TNF-inhibitor adalimumab 40 mg/week (ADA40) is the only approved treatment for hidradenitis suppurativa (HS); however, it is not uniformly effective. Despite a high p...
Read MoreError: 429: HTTP/2 429Update on Hormonal Therapy in Hidradenitis Suppurativa
April 2023 | Volume 22 | Issue 4 | | 369 | Copyright © April 2023
Hidradenitis suppurativa (HS), a chronic inflammatory disorder of the apocrine-bearing skin, presents with deep seated inflamed nodules, abscesses, draining sinus tracts, and scarring with a prof...
Read MoreError: 429: HTTP/2 429Novel Regimen of IL-17A Inhibitor Secukinumab for the Remission of Severe Hidradenitis Suppurativa: Case Report
December 2022 | Volume 21 | Issue 12 | | 1358 | Copyright © December 2022
Hidradenitis suppurativa (HS) is a morbid, recurrent skin condition that presents a major challenge to clinical therapy. Investigation into the pathogenesis of HS has implicated local and systemic pro...
Read MoreThe Incidence and Risk of Respiratory Tract Infections in Patients Using Biologics for Hidradenitis Suppurativa: A Systematic Review and Meta-analysis
August 2022 | Volume 21 | Issue 8 | | 819 | Copyright © August 2022
Background: Patients treated with biological therapy for hidradenitis suppurativa (HS) are at an increased risk of infectious complications. However, it is unclear whether these patie...
Read MoreBotulinum Toxin in Hidradenitis Suppurativa: A Systematic Review
April 2022 | Volume 21 | Issue 4 | | 408 | Copyright © April 2022
Background: Hidradenitis suppurativa disproportionately affects women, minorities, and skin of color. Botulinum toxin is a potential therapy; however, literature regarding its utility...
Read MoreSafety and Efficacy of Intense Pulsed Light With Radiofrequency in United States Hidradenitis Suppurativa Patients
April 2022 | Volume 21 | Issue 4 | | 430 | Copyright © April 2022
Copy: The combination of intense pulsed light and radiofrequency has been described in German populations to be a noninvasive therapy option for patients with hidradenitis suppurativa...
Read MoreThe Impact of Racial Differences on Treatment Strategies in Hidradenitis Suppurativa: A Retrospective Review
March 2022 | Volume 21 | Issue 3 | | 270 | Copyright © March 2022
Background: Hidradenitis suppurativa (HS) is a chronic disease that causes inflammatory lesions typically found in the axillary, inguinal, and perineal regions that can result in perm...
Read MoreUstekinumab in the Management of Hidradenitis Suppurativa: A Retrospective Study
March 2022 | Volume 21 | Issue 3 | | 319 | Copyright © March 2022
Hidradenitis suppurativa (HS) is a chronic, inflammatory skin disease characterized by the formation of recurrent abscesses in apocrine-bearing areas. In advanced stages, chronic inflammation leads to...
Read MoreA Patient-Centered Guide to Hidradenitis Suppurativa Flare Prevention
December 2021 | Volume 20 | Issue 12 | | 1295 | Copyright © December 2021
Hidradenitis suppurativa (HS) is a chronic debilitating skin disease characterized by painful dermal abscesses, subcutaneous inflammatory nodules, draining sinuses and hypertrophic scars. Prompt recog...
Read MoreA Comparison of Alternative Medicine Users and Non-Users in Patients With Hidradenitis Suppurativa
October 2021 | Volume 20 | Issue 10 | | 1072 | Copyright © October 2021
Background: Hidradenitis suppurativa patients often seek non-prescription therapies.
Objective: To determine the prevalence of alternative medicine use and char...
Read More© 2023 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
